Court Rules for DLF in Patent Suit v. Lundbeck

Law360 (November 26, 2003, 12:00 AM EST) -- Danish pharmaceutical company H. Lundbeck lost an appeal case regarding patent infringement brought by Danish generic drug maker Dansk Laegemiddelforsyning (DLF), Danish daily Jyllands-Posten reported.

DLF had appealed a court ruling from Sep. 5, 2003 that ordered it to stop selling a generic version of Lundbeck's antidepressant Cipramil in Denmark.

DLF will try to re-launch its generic version of Cipramil within 14 days, an executive told Jyllands-Posten.

A pack with 30 20-mg generic tablets produced by DLF will cost around 80 Danish crowns, compared to Lundbeck's...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.